A NEW DOSE-INTENSE EPOETIN-ALPHA REGIMEN IN ANEMIC CANCER PATIENTS RECEIVING CHEMOTHERAPY: AN OPEN-LABEL, NON-RANDOMIZED, PILOT STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles